advanced thermal therapeutics LLC

654 gramatan avenue
mt. vernon, new york 10552

NYS Entity Status
ACTIVE

NYS Filing Date
AUGUST 11, 2014

NYS DOS ID#
4619846

County
WESTCHESTER

Jurisdiction
DELAWARE

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY

Name History
2014 - ADVANCED THERMAL THERAPEUTICS LLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Trump’s Tough Talk on North Korea Puts Japan’s Leader in Delicate Spot
    By JONATHAN SOBLE - Friday Aug 11, 2017

    North Korea’s accelerating military advances — and President Trump’s volatile response — could complicate Japan’s close alliance with the United States.

    Source: NYT > Home Page
  • Olivier Vernon’s iron-man streak is done
    By Paul Schwartz - Sunday Oct 8, 2017

    Something will happen on Sunday to defensive end Olivier Vernon that has never happened to him in his NFL career, now in its sixth season. Vernon will miss a game. Vernon was declared inactive against the Chargers with a sprained ankle, not an unexpected development, considering he was not able to practice during the week....

    Source: New York Post: Sports
  • IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
    By Ben Fidler - Thursday Aug 3, 2017

    Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]

    Source: Xconomy New York
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • Antibiotics Firms Cempra, Melinta Therapeutics Agree to Merger
    By Frank Vinluan - Wednesday Aug 9, 2017

    Cempra plans to combine with Melinta Therapeutics, a merger that provides a new path forward for the Chapel Hill, NC, firm following the FDA’s surprising rejection of its lead drug late last year. Meanwhile, privately held Melinta, based in New Haven, CT, will gain a public stock listing through the deal as it prepares to […]

    Source: Xconomy New York